Why the study?
Primary adrenal lymphoma is a rare lymphoid malignancy with predominant adrenal manifestation and risk of adrenal insufficiency, and its clinical picture needed refinement.
Does isolated adrenal involvement compared to extra-adrenal involvement affect survival in patients with primary adrenal lymphoma?
Comparison
Isolated adrenal involvement (iPAL) vs additional extra-adrenal involvement (PAL+)
Design
Multicenter retrospective cohort study
Follow-up
Median 41.6 months
Key result
Isolated primary adrenal lymphoma was associated with significantly shorter progression-free survival compared to extra-adrenal involvement (HR 40.1; 95% CI 2.63-613.7; P=0.008).
Authors
Loading...
May warrant cautious prognostic assessment in isolated primary adrenal lymphoma; leaves open need for prospective validation and tailored strategies.
Cohort (n=97)
Yes
Does isolated adrenal involvement compared to extra-adrenal involvement affect survival in patients with primary adrenal lymphoma?
Hazard Ratio: 40.1 (95% CI 2.63–613.7)
p-value: p=0.008
Majidi et al. (2020) conducted a cohort in Primary adrenal lymphoma (PAL) (n=97). Isolated adrenal involvement (iPAL) vs. Extra-adrenal involvement (PAL+) was evaluated on Progression-free survival (PFS) (HR 40.1, 95% CI 2.63-613.7, p=0.008). Isolated primary adrenal lymphoma was associated with significantly shorter progression-free survival compared to extra-adrenal involvement (HR 40.1; 95% CI 2.63-613.7; P=0.008).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: